With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

Karen Alter
Why the Best Leaders Don’t Climb Straight Ladders: How Karen Alter Built Success Through Detours
November 24, 2025

As companies push to decarbonize, modernize infrastructure, and bring new technologies to market, the leaders who stand out aren’t always the ones who followed a straight career path. Increasingly, it’s the people with the zigzags—the folks who’ve worked across different industries, adapted to new environments, and learned to make decisions under pressure—who bring the clarity…

Read More
intuition
Allowing Inspiration to Grow from Intuition: How Inner Guidance Drives Real Career Growth
November 21, 2025

In a workplace culture increasingly shaped by rapid change, rising expectations, and new definitions of leadership, professionals are redefining success beyond titles and output. Empathy, intuition, and inner alignment — once seen as intangible “nice-to-haves” — are now emerging as competitive advantages. As recent workforce studies show that human-centered leaders drive higher engagement and…

Read More
SEO
SEO in the Age of AI: What CMOs and CEOs Need to Know About AEO and GEO
November 20, 2025

In an era when AI-driven search experiences are reshaping how customers discover brands, marketing leaders are navigating a confusing landscape of new acronyms, shifting behaviors, and bold industry predictions. Despite widespread claims that “SEO is dead,” the data tells a different story: organic search traffic has continued to grow even as platforms like ChatGPT, Gemini,…

Read More
From the Bench: How Research Can Help Us Build a Future-Ready Global Healthcare Workforce | Lauren Herckis | EP 18
From the Bench: How Research Can Help Us Build a Future-Ready Global Healthcare Workforce
November 20, 2025

The Care Anywhere podcast is taking listeners behind the scenes of global health workforce research with a brand-new series: From the Bench. In this kickoff episode, host Lea Sims talks with Dr. Lauren Herckis of TruMerit about how research can move from data to real-world impact — revealing how evidence, collaboration, and curiosity are driving…

Read More